Form 4/A for RMD ResMed|
Accepted 2022-01-04 00:00:00 ET · period of report 2021-11-16 · accession 0001127602-22-000624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2022-01-04 | 2021-11-16+ | RMD | Leong Justin | Pres, Asia Latin America | A - Grant | $238.22 | +9,800 | 49.9K | +24% | +$2.33M |
| A | 2022-01-04 | 2021-12-31 | RMD | Leong Justin | Pres, Asia Latin America | F - Tax | $259.47 | -562 | 49.3K | -1% | -$145.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ReMed Common Stock | 2021-11-18 | A | A | 638 | $0.00 | 49,933 | D | — | — | |
| 2 | Common | ReMed Common Stock | 2021-11-16 | A | A | 9,162 | $254.81 | 49,857 | D | — | — | |
| 3 | Common | ReMed Common Stock | 2021-12-31 | F | D | 562 | $259.47 | 49,295 | D | — | — |